Back to search results

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE1

Conditions

Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Research Site, Tucson, Arizona, United States

  • Research Site, Aurora, Colorado, United States

  • Research Site, Washington D.C., District of Columbia, United States

  • Research Site, St Louis, Missouri, United States

  • Research Site, New York, New York, United States

  • Research Site, New York, New York, United States

  • Research Site, Cleveland, Ohio, United States

  • Research Site, Seattle, Washington, United States

  • Research Site, Milwaukee, Wisconsin, United States

  • Research Site, Liverpool, Australia

  • Research Site, Melbourne, Australia

  • Research Site, Melbourne, Australia

  • Research Site, Waratah, Australia

  • Research Site, Montreal, Quebec, Canada

  • Research Site, Leipzig, Germany

  • Research Site, Magdeburg, Germany

  • Research Site, Würzburg, Germany

  • Research Site, Cambridge, United Kingdom

  • Research Site, London, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)